Advances in the care of patients with chronic hepatitis c infection in Connecticut: Epidemiology, screening, and treatment

Thomas R. McCARTY; Andrea Lombard; Joseph K. Lim

Advances in the care of patients with chronic hepatitis c infection in Connecticut: Epidemiology, screening, and treatment

Thomas R. McCARTY, Andrea Lombard, Joseph K. Lim

Research output: Contribution to journal › Article › peer-review

Abstract

Despite the variable course of hepatitis C virus (HCV) infection, HCV is estimated to account for approximately 40% of all chronic liver disease in the US. This significant burden of HCV infection within the US parallels the current challenges within the state of Connecticut. While barriers to HCV treatment and issues with access to care persist, this review will serve to describe the current landscape of HCV infection in CT. Furthermore, the primary aim of this article is to provide physicians with current epidemiologic trends, screening guidelines, keys to initial management, available therapies, and strategies to improve access for individuals within the state.

Original language	English (US)
Pages (from-to)	197-205
Number of pages	9
Journal	Connecticut Medicine
Volume	82
Issue number	4
State	Published - Apr 2018

Keywords

Cirrhosis
Connecticut
Hepatitis C virus (HCV)
Liver disease
Sustained viral response (SVR)

ASJC Scopus subject areas

Medicine(all)

Cite this

@article{cf112cc86df54dc5b294875a44a18166,

title = "Advances in the care of patients with chronic hepatitis c infection in Connecticut: Epidemiology, screening, and treatment",

abstract = "Despite the variable course of hepatitis C virus (HCV) infection, HCV is estimated to account for approximately 40% of all chronic liver disease in the US. This significant burden of HCV infection within the US parallels the current challenges within the state of Connecticut. While barriers to HCV treatment and issues with access to care persist, this review will serve to describe the current landscape of HCV infection in CT. Furthermore, the primary aim of this article is to provide physicians with current epidemiologic trends, screening guidelines, keys to initial management, available therapies, and strategies to improve access for individuals within the state.",

keywords = "Cirrhosis, Connecticut, Hepatitis C virus (HCV), Liver disease, Sustained viral response (SVR)",

author = "McCARTY, {Thomas R.} and Andrea Lombard and Lim, {Joseph K.}",

year = "2018",

month = apr,

language = "English (US)",

volume = "82",

pages = "197--205",

journal = "Connecticut Medicine",

issn = "0010-6178",

publisher = "Connecticut State Medical Society",

number = "4",

}

TY - JOUR

T1 - Advances in the care of patients with chronic hepatitis c infection in Connecticut

T2 - Epidemiology, screening, and treatment

AU - McCARTY, Thomas R.

AU - Lombard, Andrea

AU - Lim, Joseph K.

PY - 2018/4

Y1 - 2018/4

N2 - Despite the variable course of hepatitis C virus (HCV) infection, HCV is estimated to account for approximately 40% of all chronic liver disease in the US. This significant burden of HCV infection within the US parallels the current challenges within the state of Connecticut. While barriers to HCV treatment and issues with access to care persist, this review will serve to describe the current landscape of HCV infection in CT. Furthermore, the primary aim of this article is to provide physicians with current epidemiologic trends, screening guidelines, keys to initial management, available therapies, and strategies to improve access for individuals within the state.

AB - Despite the variable course of hepatitis C virus (HCV) infection, HCV is estimated to account for approximately 40% of all chronic liver disease in the US. This significant burden of HCV infection within the US parallels the current challenges within the state of Connecticut. While barriers to HCV treatment and issues with access to care persist, this review will serve to describe the current landscape of HCV infection in CT. Furthermore, the primary aim of this article is to provide physicians with current epidemiologic trends, screening guidelines, keys to initial management, available therapies, and strategies to improve access for individuals within the state.

KW - Cirrhosis

KW - Connecticut

KW - Hepatitis C virus (HCV)

KW - Liver disease

KW - Sustained viral response (SVR)

UR - http://www.scopus.com/inward/record.url?scp=85044942909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044942909&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85044942909

SN - 0010-6178

VL - 82

SP - 197

EP - 205

JO - Connecticut Medicine

JF - Connecticut Medicine

IS - 4

ER -

Advances in the care of patients with chronic hepatitis c infection in Connecticut: Epidemiology, screening, and treatment

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this